Rockefeller Capital Management’s Oncolytics Biotech ONCY Stock Holding History

Rockefeller Capital Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.8K	Hold	20,939	–	–	﹤0.01%	3753
2025 Q4	$18.3K	Hold	20,939	–	–	﹤0.01%	3549
2025 Q3	$29.3K	Buy	+20,939	New	+$23.5K	﹤0.01%	3166
2023 Q1	–	Sell	-5,540	Closed	-$9K	–	3280
2022 Q4	$9K	Hold	5,540	–	–	﹤0.01%	3138
2022 Q3	$6K	Hold	5,540	–	–	﹤0.01%	3291
2022 Q2	$5K	Hold	5,540	–	–	﹤0.01%	3464
2022 Q1	$8K	Hold	5,540	–	–	﹤0.01%	3166
2021 Q4	$7K	Hold	5,540	–	–	﹤0.01%	3156
2021 Q3	$11K	Hold	5,540	–	–	﹤0.01%	2855
2021 Q2	$15K	Hold	5,540	–	–	﹤0.01%	2611
2021 Q1	$21K	Buy	5,540 +2,000	+56%	+$5.97K	﹤0.01%	2261
2020 Q4	$8K	Hold	3,540	–	–	﹤0.01%	2306
2020 Q3	$5K	Buy	3,540 +2,994	+548%	+$5.49K	﹤0.01%	2235
2020 Q2	$1K	Sell	546 -105	-16%	-$198	﹤0.01%	2479
2020 Q1	$1K	Hold	651	–	–	﹤0.01%	2297
2019 Q4	$3K	Buy	+651	New	+$735	﹤0.01%	1874

Other funds holding ONCY

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SFP

Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return

Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Rockefeller Capital Management's ONCY Position: Q1 2026 in Review

Rockefeller Capital Management held its Oncolytics Biotech (ONCY) position steady in Q1 2026 at 20,939 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3753.

Rockefeller Capital Management first reported a position in ONCY in Q4 2019 and has held it in 16 quarters since. The position peaked at $29.3K in Q3 2025. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

Rockefeller Capital Management held 20,939 shares of Oncolytics Biotech worth $17.8K as of Q1 2026.
Rockefeller Capital Management left its Oncolytics Biotech share count unchanged in Q1 2026.
Oncolytics Biotech made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3753 holding.
Rockefeller Capital Management first reported a position in Oncolytics Biotech in Q4 2019 and has held it in 16 quarters since.
Rockefeller Capital Management's Oncolytics Biotech position peaked at $29.3K in Q3 2025.
59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.